Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Cholinesterase inhibitors and hospitalization for bradycardia: a population-based study.

Park-Wyllie LY, Mamdani MM, Li P, Gill SS, Laupacis A, Juurlink DN.

PLoS Med. 2009 Sep;6(9):e1000157. doi: 10.1371/journal.pmed.1000157. Epub 2009 Sep 29.

2.

Syncope and its consequences in patients with dementia receiving cholinesterase inhibitors: a population-based cohort study.

Gill SS, Anderson GM, Fischer HD, Bell CM, Li P, Normand SL, Rochon PA.

Arch Intern Med. 2009 May 11;169(9):867-73. doi: 10.1001/archinternmed.2009.43.

PMID:
19433698
4.

Anticholinergic Drug Burden in Persons with Dementia Taking a Cholinesterase Inhibitor: The Effect of Multiple Physicians.

Reppas-Rindlisbacher CE, Fischer HD, Fung K, Gill SS, Seitz D, Tannenbaum C, Austin PC, Rochon PA.

J Am Geriatr Soc. 2016 Mar;64(3):492-500. doi: 10.1111/jgs.14034.

5.

A prescribing cascade involving cholinesterase inhibitors and anticholinergic drugs.

Gill SS, Mamdani M, Naglie G, Streiner DL, Bronskill SE, Kopp A, Shulman KI, Lee PE, Rochon PA.

Arch Intern Med. 2005 Apr 11;165(7):808-13.

PMID:
15824303
6.

Cholinesterase inhibitors and incidence of bradycardia in patients with dementia in the veterans affairs new England healthcare system.

Hernandez RK, Farwell W, Cantor MD, Lawler EV.

J Am Geriatr Soc. 2009 Nov;57(11):1997-2003. doi: 10.1111/j.1532-5415.2009.02488.x. Epub 2009 Sep 28.

PMID:
19793162
7.

Use of clarithromycin and adverse cardiovascular events among older patients receiving donepezil: a population-based, nested case-control study.

Hutson JR, Fischer HD, Wang X, Gruneir A, Daneman N, Gill SS, Rochon PA, Anderson GM.

Drugs Aging. 2012 Mar 1;29(3):205-211. doi: 10.2165/11599090-000000000-00000.

PMID:
22372724
8.
9.

Cholinesterase inhibitors and adverse pulmonary events in older people with chronic obstructive pulmonary disease and concomitant dementia: a population-based, cohort study.

Stephenson A, Seitz DP, Fischer HD, Gruneir A, Bell CM, Gershon AS, Fu L, Anderson GM, Austin PC, Rochon PA, Gill SS.

Drugs Aging. 2012 Mar 1;29(3):213-223. doi: 10.2165/11599480-000000000-00000.

PMID:
22332932
10.

Ticagrelor and bradycardia: a nested case-control study.

Turgeon RD, Fernandes KA, Juurlink D, Tu JV, Mamdani M.

Pharmacoepidemiol Drug Saf. 2015 Dec;24(12):1281-5. doi: 10.1002/pds.3884. Epub 2015 Oct 7.

PMID:
26448559
11.

Proton pump inhibitors and hospitalization with hypomagnesemia: a population-based case-control study.

Zipursky J, Macdonald EM, Hollands S, Gomes T, Mamdani MM, Paterson JM, Lathia N, Juurlink DN.

PLoS Med. 2014 Sep 30;11(9):e1001736. doi: 10.1371/journal.pmed.1001736. eCollection 2014 Sep.

12.

Weight Loss Associated with Cholinesterase Inhibitors in Individuals with Dementia in a National Healthcare System.

Sheffrin M, Miao Y, Boscardin WJ, Steinman MA.

J Am Geriatr Soc. 2015 Aug;63(8):1512-8. doi: 10.1111/jgs.13511. Epub 2015 Aug 3.

13.

Antipsychotic use and myocardial infarction in older patients with treated dementia.

Pariente A, Fourrier-Réglat A, Ducruet T, Farrington P, Béland SG, Dartigues JF, Moore N, Moride Y.

Arch Intern Med. 2012 Apr 23;172(8):648-53; discussion 654-5. doi: 10.1001/archinternmed.2012.28. Epub 2012 Mar 26.

PMID:
22450214
14.

Effects of cholinesterase inhibitors on postoperative outcomes of older adults with dementia undergoing hip fracture surgery.

Seitz DP, Gill SS, Gruneir A, Austin PC, Anderson G, Reimer CL, Rochon PA.

Am J Geriatr Psychiatry. 2011 Sep;19(9):803-13. doi: 10.1097/JGP.0b013e3181ff67a1.

PMID:
21873836
15.

[Severe bradycardia in general anaesthesia in a patient treated with cholinesterase inhibitors for dementia].

Jellinge ME, Ferguson AH.

Ugeskr Laeger. 2015 Feb 9;177(7). pii: V05140311. Danish.

PMID:
25697071
16.

Anticholinesterase-induced symptoms improved by pacemaker implantation in patients with Alzheimer's disease: analysis of 6 cases.

Osmonov D, Özcan KS, Erdinler I, Altay S, Turkkan C, Yildirim E, Gurkan K.

Am J Alzheimers Dis Other Demen. 2012 Aug;27(5):311-4. doi: 10.1177/1533317512452040.

PMID:
22815079
17.

Cholinesterase inhibitors and the risk of pulmonary disorders in hospitalized dementia patients.

Helou R, Rhalimi M.

J Popul Ther Clin Pharmacol. 2010 Fall;17(3):e379-89. Epub 2010 Oct 26.

PMID:
21041864
18.

Proton pump inhibitors and hospitalization for Clostridium difficile-associated disease: a population-based study.

Lowe DO, Mamdani MM, Kopp A, Low DE, Juurlink DN.

Clin Infect Dis. 2006 Nov 15;43(10):1272-6. Epub 2006 Oct 13.

PMID:
17051491
19.

Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.

Rolinski M, Fox C, Maidment I, McShane R.

Cochrane Database Syst Rev. 2012 Mar 14;(3):CD006504. doi: 10.1002/14651858.CD006504.pub2. Review.

PMID:
22419314
20.

Significance of syncope in patients with Alzheimer's disease treated with cholinesterase inhibitors.

Bordier P, Garrigue S, Barold SS, Bressolles N, Lanusse S, Clémenty J.

Europace. 2003 Oct;5(4):429-31.

PMID:
14753643

Supplemental Content

Support Center